Clinical Advances and New Insights in the Management of Pediatric Atopic Dermatitis - Primer
Atopic dermatitis is a complex immune disease that has several distinct manifestations across age groups. Published evidence has shown that significant gaps exist in the management of AD, including an under-diagnosis of both children and adults and an incomplete evidence-base for the use of traditional AD therapies across pediatric patients. In addition, most patients and clinicians are not satisfied with current treatments for AD. New agents approved and several that are in development have the potential to address some of these gaps, and clinicians will need additional education on the rationale and data behind these agents in order to incorporate them into clinical practice when developing individualized treatment options for AD patients. This educational primer focuses on the diagnosis, common pharmacological and non-pharmacological treatments for pediatric AD, and resources. Participants will be able to review the data and learn at their own pace. The primer will also include a call for questions, challenging patient cases, and challenging diagnoses to be submitted from the participants.
This activity is designed for an audience of physicians, nurses, pharmacists and other healthcare professionals.
Upon completion of the educational activity, participants should be able to:
- Identify AD based on the evaluation of clinical characteristics specific to infants, children, and adolescents
- Examine the efficacy and safety of current non-pharmacological and pharmacological treatments for AD patients across the age spectrum
Lawrence Schachner, MD
Professor in the Department of Dermatology, Professor of Pediatrics, and Co-Director of the Division of Pediatric Dermatology at the University of Miami, Miller School of Medicine. He is also Chair Emeritus of the Department of Dermatology and the Stiefel Chair
Mercedes Gonzalez, MD
Medical Director, Pediatric Dermatology of Miami
Assistant Professor, University of Miami Miller School of Medicine,
Dr. Phillip Frost Department of Dermatology and Herbert Wertheim College of Medicine
Fernanda Schmidt, MD
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDERM. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 0.25 Contact Hours.
Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and Tarsus Cardio dba LiVDERM
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge -based activity for 0.25 contact hour(s) 0.025 CEUs). UAN 0077-9999-20-016-H04-P. Release Date: September 5, 2020
This activity is supported by an educational grant from Pfizer Inc.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.
- 0.25 ACPE Pharmacy
- 0.25 AMA PRA Category 1 Credit™
- 0.00 ANCC
- 0.25 Participation
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.